Special Article: Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/3tnpk43ud0 #addiction #DEI https://t.co/17z3EGIKn4
Racial Inequality in Receipt of Medications for Opioid Use Disorder.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2023 – Jul 2024Where it's discussed
-
X / Twitter103 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions emphasize the alarming disparities in access to medications for opioid use disorder, with contributors citing statistics like White patients receiving buprenorphine 80% more than Black patients. Phrases like 'must do better' and references to 'alarming disparity' highlight a sense of urgency and frustration, demonstrating the emotional and societal weight of the issue. The tone of concern suggests a widespread acknowledgement of the need for systemic change.
Overall, the discussions reflect a consensus that supports the findings of the publication, though there are moments of skepticism about the ongoing nature of such studies.
The discussions show a high level of curiosity and relevance, especially regarding racial disparities in healthcare.
While many posts share information, few delve deeply into the methodologies or implications, suggesting moderate engagement levels.
Many contributors perceive the findings as having significant implications for healthcare practices and policies.
Abstract in brief
- Racial and ethnic disparities exist in the treatment of opioid use disorder (OUD) in the U.S., with Black individuals experiencing higher opioid overdose mortality rates compared to other groups.
- Analysis of Medicare claims data from 2016-2019 revealed that Black patients received medications for OUD, such as buprenorphine and naloxone, at significantly lower rates than White and Hispanic patients.
- The study showed persistent racial differences in access to medication treatment for OUD, highlighting a need for addressing these disparities in healthcare.
Top posts
Most liked on X and BlueskyNot teaching about SDOH means your physician will ignore how Black patients are less likely than white patients to get life saving treatment for opiate use disorder https://t.co/JuvJ1BO9cY
ICYMI: The science of #Pharmacoequity is everywhere. Just last week an @NEJM “Special Article” on racial disparities in the use of medications for opioid use disorder. The results (figure) are pretty devastating.
Despite the continuing rise in #opioid-related overdose deaths, racial and ethnic inequities remain for one of the most effective treatments for opioid use disorder, according to a new large study, published in @NEJM. https://t.co/GdAESWpawO
Another "rain is wet" study. Racial Inequality in Receipt of Medications for Opioid Use Disorder | NEJM https://t.co/l70GE2gw7u
"Racial Inequality in Receipt of Medications for Opioid Use Disorder" by @ml_barnett and colleagues @NEJM showing significant differences (23.3% vs. 18.7% vs. 12.7% based on race) in getting buprenorphine following severe opioid use disorder https://t.co/bge7HlPVXW https://t.co/gG1c4Pcpxp
All mentions
Eat Sleep Console Approach for Managing Neonatal Opioid Withdrawal
The Eat Sleep Console care approach shows promise as an effective method for managing neonatal opioid withdrawal syndrome compared to traditional care. This trial involving 1,305 infants indicates significant reductions…
Overview of Recent Advances in Opioid Use Disorder Treatments
This video provides quick summaries of recent studies including the promising Eat Sleep Console approach for managing neonatal opioid withdrawal syndrome. The method shows a significant reduction in discharge readiness…
RT @Maryland_MACS: As we continue to recognize #BIPOCMentalHealth this month check out this article from @NEJM that highlights the continue…
As we continue to recognize #BIPOCMentalHealth this month check out this article from @NEJM that highlights the continued racial inequity experienced when accessing medication for OUD Read the aricle here: https://t.co/d186JJmTjG
30. Race and MOUD Racial Inequality in Receipt of Medications for Opioid Use Disorder. N Engl J Med. 2023 May 11;388(19):1779-1789. https://t.co/pOteZtjkw3
Episode 30 reviews an article about racial inequality in the treatment of opioid use disorder with medications, by @ml_barnett in the @NEJM. #MOUD #RacialInequality #AMJC #addictionmedicine #opioidusedisorder #buprenorphine https://t.co/pOteZtjkw3
Episode 30: “Racial Inequality in Receipt of Medications for Opioid Use Disorder” by @ml_barnett in the @NEJM. #MOUD #RacialInequality #AMJC #addictionmedicine #opioidusedisorder #buprenorphine https://t.co/QiAKzrSK4q
Episode 30 citation: Barnett ML, Meara E, Lewinson T, Hardy B, Chyn D, Onsando M, Huskamp HA, Mehrotra A, Morden NE. Racial Inequality in Receipt of Medications for Opioid Use Disorder. N Engl J Med. 2023 May 11;388(19):1779-1789. https://t.co/pOteZtjkw3
RT @AddictionMedJC: The next Addiction Medicine Journal Club podcast is coming on Monday. Get the article by @ml_barnett from @NEJM now so…
Barnett ML, Meara E, Lewinson T, Hardy B, Chyn D, Onsando M, Huskamp HA, Mehrotra A, Morden NE. Racial Inequality in Receipt of Medications for Opioid Use Disorder. N Engl J Med. 2023 May 11;388(19):1779-1789.
The next Addiction Medicine Journal Club podcast is coming on Monday. Get the article by @ml_barnett from @NEJM now so you can join the conversation. “Racial Inequality in Receipt of Medications for Opioid Use Disorder.” https://t.co/pOteZtjkw3
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
https://t.co/LRPOf5dHdV
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
Racial Inequality in Receipt of Medications for Opioid Use Disorder The high incidence of ambulatory visits in all groups showed that disparities persisted despite frequent health care contact. https://t.co/4oyEWThMkD
Racial inequality in receipt of medications for opioid use disorder. https://t.co/KQYKJFzW36
RT @DrMichaelMensah: Not teaching about SDOH means your physician will ignore how Black patients are less likely than white patients to get…
Not teaching about SDOH means your physician will ignore how Black patients are less likely than white patients to get life saving treatment for opiate use disorder https://t.co/JuvJ1BO9cY
RT @UREssien: ICYMI: The science of #Pharmacoequity is everywhere. Just last week an @NEJM “Special Article” on racial disparities in the…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @UREssien: ICYMI: The science of #Pharmacoequity is everywhere. Just last week an @NEJM “Special Article” on racial disparities in the…
RT @UREssien: ICYMI: The science of #Pharmacoequity is everywhere. Just last week an @NEJM “Special Article” on racial disparities in the…
ICYMI: The science of #Pharmacoequity is everywhere. Just last week an @NEJM “Special Article” on racial disparities in the use of medications for opioid use disorder. The results (figure) are pretty devastating.
Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/FaPdI6G8pz
A recent study in @NEJM found White patients received MOUD up to 80% more frequently than Black patients & up to 25% more frequently than Hispanic patients. Providing culturally responsive care is critical to ensuring access to lifesaving treatment. Study: https://t.co/InvRm2Ff48 https://t.co/jzpLNgQacf
Racial Inequality in Receipt of Medications for Opioid Use Disorder | NEJM https://t.co/JlR9z8Pe5M @ATDWNJ
An analysis of 2016–2019 Medicare claims data for patients with opioid use disorder showed that receipt of medications to treat OUD was more frequent among White patients than among Black and Hispanic patients. https://t.co/oKeO7Cx6uP
Racial Inequality in Receipt of Medications for Opioid Use Disorder | NEJM https://t.co/YJMXM1wvZl
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
Once just once, I would love to be surprised by a journal article about #health and #race. It would be great instead of seeing inequalities that we saw #resilience, strength & empowerment. #Equity done, right, but I guess I’ll keep waiting for that day. https://t.co/YhcLsL3Qdi
Racial Inequality in Receipt of Medications for Opioid Use Disorder | NEJM https://t.co/ydiDBXYlL8
Racial Inequality in Receipt of Medications for Opioid Use Disorder | NEJM https://t.co/F7pDuV7Smk
RT @raj_psyc: There are significant & pervasive ethnic & racial disparities in rates of medications prescribed to treat Opioid Use Disorder…
There are significant & pervasive ethnic & racial disparities in rates of medications prescribed to treat Opioid Use Disorder #OUD after an index event related to opioids (overdose or complications) @NEJM https://t.co/FTb9wPwrtm
Anew national study in the New England Journal of Medicine, led by researchers at Geisel and Harvard's T.H. Chan School of Public Health, show an alarming disparity in the treatment for opioid use disorder among whites, black, and hispanics – https://t.co/n56KM8voZT
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @NEJM: An analysis of 2016–2019 Medicare claims data for patients with opioid use disorder showed that receipt of medications to treat O…
RT @NEJM: Special Article: Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/3tnpk43ud0 #addiction #DEI ht…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @StigmabaseO: [CA] Racial Inequality in Receipt of Medications for Opioid Use Disorder: Abstract Background Since 2010, Black persons in…
https://t.co/UVqvnU7Hfu
RT @NEJM: Special Article: Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/3tnpk43ud0 #addiction #DEI ht…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @NEJM: Special Article: Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/3tnpk43ud0 #addiction #DEI ht…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @AmerMedicalAssn: Despite the continuing rise in #opioid-related overdose deaths, racial and ethnic inequities remain for one of the mos…
RT @AmerMedicalAssn: Despite the continuing rise in #opioid-related overdose deaths, racial and ethnic inequities remain for one of the mos…
Despite the continuing rise in #opioid-related overdose deaths, racial and ethnic inequities remain for one of the most effective treatments for opioid use disorder, according to a new large study, published in @NEJM. https://t.co/GdAESWpawO
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @NEJM: Special Article: Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/3tnpk43ud0 #addiction #DEI ht…
This is an abomination on so many levels. We must do better. https://t.co/H91Zd7zga7
RT @NEJM: Special Article: Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/3tnpk43ud0 #addiction #DEI ht…
RT @NEJM: Special Article: Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/3tnpk43ud0 #addiction #DEI ht…
Special Article: Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/3tnpk43ud0 #addiction #DEI https://t.co/17z3EGIKn4
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
"Racial Inequality in Receipt of Medications for Opioid Use Disorder" by @ml_barnett and colleagues @NEJM showing significant differences (23.3% vs. 18.7% vs. 12.7% based on race) in getting buprenorphine following severe opioid use disorder https://t.co/bge7HlPVXW https://t.co/gG1c4Pcpxp
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @bermaninstitute: Racial Inequality in Receipt of Medications for Opioid Use Disorder | NEJM https://t.co/cfQ2lb9i60
Racial Inequality in Receipt of Medications for Opioid Use Disorder | NEJM https://t.co/cfQ2lb9i60
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
[CA] Racial Inequality in Receipt of Medications for Opioid Use Disorder: Abstract Background Since 2010, Black persons in the United States have had a greater increase in opioid overdose–related mortality than other ... View article... https://t.co/w3qVSQgeBO
Racial Inequality in Receipt of Medications for Opioid Use Disorder | NEJM https://t.co/9RdaAWsw4R
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @CarlosdelRio7: Racial Inequality in Receipt of Medications for OUD @NEJM https://t.co/McGKr27A3M “Racial/ethnic differences in the rec…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @CDUHR_NYC: Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/pNAt2AYQ4A
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
Racial Inequality in Receipt of Medications for Opioid Use Disorder https://t.co/pNAt2AYQ4A
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
RT @ml_barnett: New @NEJM out today!! After a high risk OUD event (OD or detox) - White patients get buprenorphine 80% more often than Bla…
Another "rain is wet" study. Racial Inequality in Receipt of Medications for Opioid Use Disorder | NEJM https://t.co/l70GE2gw7u
Racial Inequality in Receipt of Medications for Opioid Use Disorder | NEJM https://t.co/KxFcaGelPA “Racialðnic differences in receipt of meds to treat OUD after an index event related to this disorder among patients with disability were substantial& did’nt change over time”